NetScientific PLC Wanda Appoints Digital Health Non-Exec Director
08 September 2016 - 4:01PM
RNS Non-Regulatory
TIDMNSCI
NetScientific PLC
08 September 2016
("NetScientific" or the "Company" or the "Group")
Wanda Strengthens its Board with Digital Health Non-Executive
Director
Derek Newell brings decades of digital health expertise
London, UK - 08 September 2016 - NetScientific plc
("NetScientific", AIM:NSCI), the transatlantic healthcare IP
commercialisation Group, announces that one of its portfolio
companies, Wanda, has appointed a new Non-Executive Director, Derek
Newell, to its Board.
Commenting on the news, François R. Martelet, Chief Executive
Officer of NetScientific and Chairman of Wanda, said: "Derek is a
highly regarded and knowledgeable industry leader with vast
experience in the field of innovative health technology. We are
delighted that Wanda has further strengthened its Board with a
digital health expert of his calibre."
The full text of the announcement issued by Wanda on 07
September 2016 is as follows:
Wanda Appoints Jiff CEO Derek Newell an Outside Director
Newell brings decades of digital health expertise to the Wanda
board
SAN FRANCISCO - 07 September, 2016 - Wanda(TM), recognized for
bringing new and proven technologies to home-centered care, today
announced the appointment of Derek Newell as an outside director.
Newell is currently CEO of Jiff, a provider of an enterprise health
benefits platform.
"Derek pioneered the use of remote patient monitoring
technologies and will be an invaluable addition to the Wanda
board," said Steve Curd, Wanda's CEO. "As we continue to enhance
the Wanda offering, I am confident that Derek will offer tremendous
insights and provide us with a unique perspective as we continue to
advance our technical, operational, and financial objectives."
Newell brings 20 years of experience as a leader of innovative
health technology and service companies. Prior to joining Jiff as
CEO, Newell was president and CEO of Robert Bosch Healthcare and
worked with the management team to build Bosch into the world's
largest remote patient monitoring company. Before Bosch he was CEO
of remote patient monitoring company Health Hero Networks, which
sold to Bosch in 2007. Health Hero Network was the first company to
get an internet connected medical device approved by the FDA.
Newell also served as chief marketing officer of LifeMasters, where
he helped pioneer the first patient-centric disease management
platform and built one of the largest disease management companies
in the US. Derek holds graduate degrees in business and public
health from UC Berkeley.
"I'm deeply committed to advancing the development of innovative
technologies that reduce the cost chronic disease and enhance the
lives of individuals with chronic conditions," said Newell. "I am
impressed with the potential of the Wanda platform to solve some of
healthcare's toughest challenges, based on how elegantly it
converges proven machine-learning analytics and behavioral science.
Wanda's ability to deliver ongoing risk analysis and decision
support is better equipping individuals to care for themselves and
allowing clinicians to more efficiently engage with consumers who
are in most need of their assistance."
- Ends -
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800
François R. Martelet,
M.D., CEO
Ian Postlethwaite, CFO
Consilium Strategic Tel: +44 (0)20 3709 5700
Communications netscientific@consilium-comms.com
Mary-Jane Elliott /
Chris Gardner / Jessica
Hodgson / Chris Welsh
/ Laura Thornton
About NetScientific Plc
NetScientific is a transatlantic healthcare technology group
with an investment strategy focused on sourcing, funding and
commercialising technologies that significantly improve the health
and well-being of people with chronic diseases. For more
information, please visit the website at www.netscientific.net
About Wanda
San Francisco-based Wanda is dedicated to advancing the
effectiveness and efficiency of medicine by using machine learning
in place of conventional technologies and by enabling clinicians to
make more informed care decisions. Wanda recognizes that remote
monitoring and algorithms cannot save lives or reduce
hospitalizations unless the individual and their caregivers are
promptly informed and highly engaged. Through the collaboration of
data science and applied medical research, Wanda has proven that
its inline analytics predict preventable events much better than
conventional methods. Wanda serves as a diligent companion,
providing encouragement and intelligent visual guidance that
simplifies and improves lives, while simultaneously helping
organizations reduce their care delivery costs. Wanda is a
NetScientific portfolio company. More information about Wanda can
be found at www.yourwanda.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRALLFSRAVIDIIR
(END) Dow Jones Newswires
September 08, 2016 02:01 ET (06:01 GMT)
Netscientific (LSE:NSCI)
Historical Stock Chart
From Apr 2024 to May 2024
Netscientific (LSE:NSCI)
Historical Stock Chart
From May 2023 to May 2024